Related Experiment Videos
Death receptors and apoptosis. Deadly signaling and evasive tactics
1Department of Pathology, University of Michigan Medical School, Ann Arbor 48109, USA. vincenz@umich.edu
Abstract:
The availability of large amounts of sequence data has made it possible to identify death receptors by homology. Because the genome has not been analyzed completely, a few additional members of this family probably will be identified in the next few years. Rapid progress also has been made recently on the signaling mechanisms used by the death receptors. Considerable conservation of the intracellular signaling mechanisms is seen between different receptors suggesting that it is unlikely that new elements will be added to the molecular framework of death receptor signaling. The analysis of signaling mechanisms has exposed the complexity and multiplicity of cellular responses on death receptor activation. It is not surprising, therefore, that understanding the biological function the death receptors lags behind their characterization at the molecular level. In particular, the role of death receptors in many disease states, such as myocardial disease, remains to be elucidated. (38) This complexity in death-receptor function has constrained their potential for pharmacological manipulation. In most cases it is not sufficient to simply activate a specific death receptor. Manipulation of only one of the multiple responses induced by the receptor is desirable. Currently, no solutions to this challenge have been applied. The exception to this conundrum may be TRAIL. Injection of recombinant TRAIL has few side effects in animal studies and combination therapies that use TRAIL as a radiation sensitizer show early promise.
Insights
Identifying death receptors through sequence data is advancing, but their complex biological roles and disease implications, especially in myocardial disease, require further study. TRAIL shows therapeutic promise, particularly in combination therapies.
Area of Science:
- Molecular Biology
- Immunology
- Genomics
Background:
- Large-scale sequence data facilitates homology-based identification of death receptors.
- Recent advancements have elucidated the signaling mechanisms of death receptors.
- Intracellular signaling pathways show significant conservation across different death receptors.
Purpose of the Study:
- To explore the identification and signaling mechanisms of death receptors.
- To investigate the complex cellular responses triggered by death receptor activation.
- To understand the biological functions and disease relevance of death receptors, particularly in myocardial disease.
Main Methods:
- Homology-based identification using sequence data analysis.
- Characterization of intracellular signaling pathways.
- Analysis of cellular responses to death receptor activation.
Main Results:
- Several death receptor family members have been identified, with more expected.
- Death receptor signaling involves conserved intracellular mechanisms but elicits complex cellular responses.
- The precise biological functions and roles in diseases like myocardial disease are still under investigation.
Conclusions:
- While death receptor identification and signaling are well-characterized, their biological roles and therapeutic manipulation remain challenging.
- The complexity of death receptor signaling complicates targeted pharmacological intervention.
- Recombinant TRAIL (TNF-related apoptosis-inducing ligand) and its use in combination therapies, such as radiation sensitization, show potential with few side effects in preclinical studies.